# A 90 Day Observational Study as an Extension to the Phase 3,Open Labeled Exploratory Study of RELiZORB

> **NCT05635747** · — · ENROLLING_BY_INVITATION · sponsor: **Boston Children's Hospital** · enrollment: 32 (estimated)

## Conditions studied

- Short Bowel Syndrome
- Malabsorption

## Interventions

- **DEVICE:** Relizorb Enzyme Cartridge

## Key facts

- **NCT ID:** NCT05635747
- **Lead sponsor:** Boston Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2022-09-29
- **Primary completion:** 2026-09-29
- **Final completion:** 2027-09-29
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2025-12-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05635747

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05635747, "A 90 Day Observational Study as an Extension to the Phase 3,Open Labeled Exploratory Study of RELiZORB". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05635747. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*